Officer Dennis Mulroy Files to Sell Additional $1.03M in Stock, Continuing Recent Trend
ANAB has more than doubled off its 52-week low of $11.402 on light trading volume (0.2× avg).
Summary
Officer Dennis Mulroy has filed to sell an additional $1.03 million in company stock, extending a recent pattern of significant insider selling that totals over $8.8 million in the last three months.
Key Events · Ownership and Investor Activity · ANAB
-
Officer Files Intent to Sell
Officer Dennis Mulroy has filed a Form 144 indicating intent to sell 20,000 shares of common stock, with an approximate market value of $1,035,438.00.
-
Continuation of Selling Pattern
This filing is the latest in a series of sales by Dennis Mulroy, who has sold a cumulative total of 138,422 shares, generating gross proceeds of $7,797,889.52, in the past three months, in addition to this proposed sale.
-
Option Exercise and Sale
The shares to be sold were acquired through a stock option exercise on the same day as the proposed sale date, indicating a liquidity event rather than a direct open-market sale of previously held shares.
-
Conflicting Capital Allocation Signals
The ongoing insider selling by an officer contrasts with the company's recent announcement of a $100 million share repurchase program, creating mixed signals regarding capital allocation and insider confidence.
Analysis · ANAB · Life Sciences
Officer Dennis Mulroy has filed to sell an additional $1.03 million worth of common stock. This transaction is part of a sustained pattern of insider selling by Mulroy, who has sold over $8.8 million in shares over the past three months. This ongoing distribution by a key officer, often involving the exercise of stock options followed by immediate sale, presents a negative signal, especially as it occurs after the company announced a $100 million share repurchase program.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 36.1% of the 1051 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.56%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ANAB was trading at $51.33 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.5B. The 52-week trading range was $11.40 to $72.36. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.